Dave Rosa
Chief Executive Officer
Replay available
NeuroOne Medical Technologies Corporation (NMTC) Q3 2025 Earnings Call
NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) Q3 2025 earnings conference call, held 2025-08-14. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Ron McClurg
Chief Financial Officer
Jeffrey Cohen
Analyst, Ladenburg
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Neuroone Medical Technologies Corporation.
Replay transcript excerpt
WEBVTT 00:00:00.031 -- 00:00:06.400 Good day, ladies and gentlemen. Welcome to the third quarter of fiscal year 2025 00:00:06.400 -- 00:00:07.922 financial 00:00:07.922 -- 00:00:13.788 results conference call for NeuroOne Medical Technologies Corporation. 00:00:13.991 -- 00:00:20.020 Today's call will be conducted by the company's chief executive officer, Dave Rosa, 00:00:20.020 -- 00:00:24.826 and Ron McClurg, the company's chief financial officer. 00:00:24.826 -- 00:00:30.777 Chris Volker, the company's chief operating officer, will also be in attendance. 00:00:30.777 -- 00:00:35.702 Before I turn the call over to Mr. Rosa, I'd like to remind you that this conference 00:00:35.702 -- 00:00:40.047 call will include forward-looking statements within the meaning of U.S. 00:00:40.047 -- 00:00:45.473 federal securities laws with respect to future operations, financial results, 00:00:45.473 -- 00:00:51.219 events, trends, and performance, which are based on management's beliefs and assumptions 00:00:51.219 -- 00:00:53.761 as of today's call. 00:00:53.761 -- 00:00:59.785 Forward-looking statements, including statements regarding our fiscal 2025 guidance, 00:00:59.785 -- 00:01:05.030 may involve known and unknown risks, uncertainties, and other factors which may 00:01:05.030 -- 00:01:11.316 cause actual results to differ materially from those expressed or implied by such statements. 00:01:11.316 -- 00:01:16.601 See Neuro One's financial results press release and SEC filings for information 00:01:16.601 -- 00:01:23.108 regarding specific risks and uncertainties that could cause actual results to differ. 00:01:23.108 -- 00:01:28.293 Except as required by law, Neuro One undertakes no obligation to update 00:01:28.293 -- 00:01:30.937 such forward-looking statements 00:01:30.937...